Orbit Biomedical, Inc. Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Orbit Biomedical, Inc. is a biotechnology company focused on medical devices and processes that enable precise delivery of gene and cell therapies to the sub-retinal space. It sits at the intersection of biomedical engineering, surgeon training, and curative therapeutics, with the goal of improving the precision and safety of retinal treatments. The work targets blinding retinal conditions by supporting targeted delivery of therapies. In 2019, Orbit merged with Gyroscope Therapeutics to form a fully integrated clinical-stage retinal gene therapy company with capabilities in manufacturing and a surgical platform for accurate, safe delivery. Based in Philadelphia, Pennsylvania, and Stevenage, United Kingdom, the company serves clinicians and patients seeking advanced retinal therapies and represents a small to mid-sized organization.